| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 2 | 4 | — | — | — | 12 | 1 | 6 | 2 | — | 7 | 4 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡ |
|
| 2026 | 1.01 |
—
—
—
|
| 2025 | 1.02 |
—
—
—
—
|
| 2024 | 1.01 |
—
—
—
—
|
| 2023 | 0.93 |
—
—
—
—
|
| 2022 | 0.41 |
—
—
—
|
| 2021 | ‡‡‡ |
|
| 2020 | 0.93 |
—
—
—
|
| 2019 | 1.14 |
—
—
—
—
|
| 2018 | 0.96 |
—
—
—
—
|
| 2017 | 0.60 |
—
—
—
—
|
| 2016 | 0.60 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 821.80 | 735.60 | 625.80 | 628.60 |
| Receivables | 783.70 | 617.60 | 648.70 | 866.30 |
| Inventory | 941.20 | 893.20 | 726.00 | 999.30 |
| Other | 77.80 | 85.50 | 67.50 | 108.70 |
| 2,666.00 | 2,331.90 | 2,068.00 | 2,602.90 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,814.30 | 1,813.80 | 1,633.80 | 1,853.00 |
| ST’ Debt | 44.50 | 9.50 | 9.50 | 8.50 |
| Other | 0.40 | — | — | — |
| 2,685.10 | 2,516.00 | 2,529.40 | 3,411.30 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,653.10 | 4,087.00 | — | — |
—
|
| ’25 | 2,641.90 | 2,764.60 | 2,887.00 | 2,429.40 |
10,722.90
|
| ’24 | 3,128.00 | 3,308.10 | 3,042.40 | 2,373.70 |
11,852.20
|
| ’23 | 3,924.30 | 4,195.60 | 4,628.80 | 3,718.50 |
16,467.20
|
| ’22 | 4,459.10 | 5,982.60 | 5,324.90 | 4,034.40 |
19,801.00
|
| ’21 | 2,392.20 | 2,191.50 | 2,956.50 | 3,108.00 |
10,648.20
|
| ’20 | 1,821.20 | 1,535.50 | 2,062.90 | 1,882.20 |
7,301.80
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 461.10 | 262.90 | — | — |
—
|
| ’25 | (62.40) | 51.40 | 44.00 | 502.80 |
535.80
|
| ’24 | 166.70 | (48.40) | (21.60) | (163.50) |
(66.80)
|
| ’23 | 395.10 | 95.10 | 432.60 | 90.80 |
1,013.60
|
| ’22 | 26.80 | 559.10 | 130.20 | (290.80) |
425.30
|
| ’21 | (34.30) | 169.20 | 75.30 | 161.20 |
371.40
|
| ’20 | (154.10) | (169.00) | (76.70) | 116.90 |
(282.90)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 267.60 | 85.90 | — | — |
—
|
| ’25 | (198.40) | (116.30) | (65.70) | 384.50 |
4.10
|
| ’24 | 127.70 | (119.40) | (139.80) | (355.70) |
(487.20)
|
| ’23 | 183.20 | 28.80 | 389.20 | 17.50 |
618.70
|
| ’22 | (4.10) | 489.20 | 34.90 | (380.30) |
139.70
|
| ’21 | (82.90) | 95.30 | 45.50 | 102.20 |
160.10
|
| ’20 | (343.00) | (217.40) | (83.50) | 89.00 |
(554.90)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (3.34) | 2.71 | — | — |
—
|
| ’25 | (2.78) | (1.76) | 2.93 | 1.26 |
(0.38)
|
| ’24 | (0.51) | (0.58) | (1.20) | (6.55) |
(8.77)
|
| ’23 | 0.95 | (0.13) | 1.97 | (2.57) |
0.30
|
| ’22 | 0.09 | 5.05 | 0.10 | (1.73) |
3.59
|
| ’21 | (1.34) | (1.10) | 0.24 | (0.57) |
(2.75)
|
| ’20 | (4.28) | 1.18 | (1.20) | (3.98) |
(8.26)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 14.71 | 19.39 | 15.36 | 11.03 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.45 | 31.22 | 33.60 | 43.50 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,746 | 3,591 | 1,987 | 1,902 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.29 | 4.59 | 5.96 | 5.64 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19,801.00 | 16,467.20 | 11,852.20 | 10,722.90 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.78% | 3.33% | (0.36%) | 5.71% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 321.80 | 16.60 | (706.00) | 38.90 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.63% | 0.10% | (5.96%) | 0.36% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 290.50 | 46.70 | (520.90) | 43.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 275.00 | 339.50 | 374.50 | 397.80 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 279.72 | 251.77 | 185.53 | 176.64 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.63 | 0.30 | (8.77) | (0.38) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 6.01 | 15.50 | (1.05) | 8.83 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4.03) | (6.04) | (6.58) | (8.76) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.97 | 9.46 | (7.63) | 0.07 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.11 | 14.67 | 9.00 | 9.02 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 70.79 | 65.41 | 63.88 | 60.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | 7.20 | 109.88 | 0.00 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.09 | 0.10 | 0.10 | 0.17 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.71 | 1.80 | 2.05 | 3.29 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.20 | 0.21 | 0.27 | 0.41 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.90 | 5.66 | (6.59) | 1,075.07 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 425.30 | 1,013.60 | (66.80) | 535.80 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (285.60) | (394.90) | (420.40) | (531.70) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 139.70 | 618.70 | (487.20) | 4.10 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 630.50 | (19.10) | (184.10) | (461.40) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,053.70 | 2,599.80 | 2,765.20 | 3,233.10 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,212.40 | 1,778.00 | 2,029.60 | 2,607.30 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,069.50 | 959.70 | 575.20 | 547.30 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.43% | 0.26% | (8.10%) | (0.34%) | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.71% | 5.59% | (11.79%) | 5.96% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.68% | 1.95% | (73.02%) | (4.06%) | ‡‡‡‡‡ | — | — |
ROE
|
Delek US Holdings (DK), a downstream refiner with facilities across Texas, Arkansas, and Louisiana, exemplifies the oil sector’s wild volatility: revenue surged 372% from $4.2B in 2016 to $19.8B in 2022 post-Alon acquisition, only to plummet 45% cumulatively by 2024 amid weak crack spreads, yielding negative gross margins (-0.36%) and a $521M net loss (EPS -$8.77). Despite workforce cuts boosting revenue per employee 30% to $6M, ROE cratered to -73% from 2022’s 25%, while debt ballooned 233% to $2.77B, amplifying cycle risks. Free cash flow flipped negative (-$7.63/share) in 2024 after capex, though historical positives funded buybacks shrinking shares 13%.
Insiders signaled confidence with $295K buys in March 2025 at lows, but netted $10.4M sells (35x buy volume) through November amid rallies, correlating with shares recovering toward $30 highs from $15 lows. Trading at dirt-cheap PS 0.10x and EV/Sales 0.27x—13% below average analyst targets—DK’s multiples scream value if earnings rebound, yet book value per share eroded 67% to $9.
Analysts forecast 2025-2027 revenue contraction to $9.9B (-20% cumulative) but EBT positivity ($127M in 2025), EPS $0.77 by 2027, and ROE 18%, with easing capex aiding FCF recovery. High debt and thin margins pose headwinds, but geopolitics could widen spreads for upside—making DK a speculative dip-buy for volatility-tolerant investors eyeing energy rebounds.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.